The partnership is a “step toward global equity in clinical research opportunities involving the use of CAR-T cell therapies,” according to a May 23 news release.
“Equity in cancer care and research is a central goal of our mission at the Abramson Cancer Center,” said Robert Vonderheide, MD, director of Penn’s Abramson Cancer Center. “This new effort with Costa Rica exemplifies the longstanding work by Penn Medicine’s Center for Global Health to address disparities across the world.”
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.